PHARMACOLOGICAL AND PHARMACOECONOMIC ASPECTS OF USING BIOSIMILARS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

This article covers key issues and considerations related to use of biosimilars in the therapy of rheumatoid arthritis. Since significant number of new biosimilars is entering now the stage of regulatory approval process and soon will become available for prescription, substantination for detailed research of biosimilars focused on population of patients in Russia should be addressed with high importance.

Authors
Orlikhina Irina 1 , Notina E.A. 1 , Bykova I.A. 1
Conference proceedings
Modern Paradigm of the Scientific Knowledge: Actuality and Prospects: proceedings of the V International Multidisciplinary Scientific and Practical Conference in Foreign Languages
Publisher
Языки Народов Мира
Language
English
Pages
133-135
Status
Published
Year
2017
Organizations
  • 1 RUDN
Keywords
biosimilars; biologics; rheumatoid arthritis; interchangeability; immunogenicity; anti-TNF-a agents
Date of creation
10.07.2024
Date of change
10.07.2024
Short link
https://repository.rudn.ru/en/records/article/record/148728/
Share

Other records

OPTIMIZATION OF PHARMACOTHERAPY IN THE ELDERLY

Article
Mohammed A.A., Notina E.A.
Modern Paradigm of the Scientific Knowledge: Actuality and Prospects: proceedings of the V International Multidisciplinary Scientific and Practical Conference in Foreign Languages. Языки Народов Мира. 2017. P. 131-133